Citurgia Biochemicals Ltd

Citurgia Biochemicals Ltd has announced that its Board of Directors will convene on August 12, 2026. The primary agenda item is to consider and approve the unaudited financial results for the first quarter ended June 30, 2026. The trading window for company shares, which closed on July 1, 2026, will reopen 48 hours after the results are declared.

Citurgia Biochemicals Ltd has announced the closure of its trading window for all designated persons and their immediate relatives. This closure is in accordance with SEBI (LODR) Regulations, 2015 and the company's internal code of conduct for preventing insider trading. The trading window will remain shut from July 1st, 2026, until two calendar days after the board meeting where the un-audited financial results for the quarter ending June 30th, 2026, will be declared. This measure is standard practice to ensure fair disclosure and prevent potential insider trading ahead of financial result announcements.

Citurgia Biochemicals Ltd reported audited financial results for the quarter and year ended March 31, 2026. The company's total expenses for the year ended at ₹74.25 lakhs, resulting in a loss before tax of ₹74.25 lakhs. The Board of Directors approved these results in their meeting held on May 30, 2026. Trading window was closed from April 1, 2026, and will open 48 hours after the results are declared.

Citurgia Biochemicals Ltd has appointed Mr. Kashi Nath Jha as Chief Financial Officer (CFO) and Key Managerial Personnel, effective May 29, 2026. The appointment follows the recommendation of the Nomination and Remuneration Committee and was approved by the Board of Directors in a meeting held on the same date. Mr. Jha brings 28 years of experience in finance and accounts, with expertise in feasibility studies, strategic financial planning, and risk mitigation.

Citurgia Biochemicals Ltd has announced a Board of Directors meeting scheduled for May 30, 2026, to consider and approve the audited financial results for the quarter and year ended March 31, 2026. The trading window for the company's equity shares has been closed since April 1, 2026, and will reopen 48 hours after the financial results are declared.

Citurgia Biochemicals Ltd has announced the closure of its trading window for all designated persons and their immediate relatives. The closure is in accordance with the company's Code of Conduct for Prevention of Insider Trading and SEBI (LODR) Regulations, 2015. The trading window is closed from 01st April, 2026 until 2 (two) calendar days after the Board meeting date for the declaration of Audited financial results for the quarter and year ending on 31st March, 2026.

Citurgia Biochemicals Ltd has announced its unaudited financial results for the quarter ended on 31st December 2025. The total revenue for the quarter is INR 42.31 Lakhs, a decrease from the preceding quarter and the corresponding quarter of the previous fiscal year. The company reported a profit before tax of INR 2.31 Lakhs, an improvement compared to the losses in the preceding and corresponding quarters. The profit for the period from continuing operations stands at INR 2.31 Lakhs. There are no investor complaints pending at the beginning, end, or during the quarter. The financial results have been prepared in accordance with applicable Indian Accounting Standards and other recognized accounting practices.

Citurgia Biochemicals Ltd has announced its unaudited financial results for the quarter ended on 31st December 2025. The total revenue stands at INR 42.31 Lakhs, with a profit before tax of INR 2.31 Lakhs. The company's earnings per equity share for continuing operations are INR 0.005 for both basic and diluted categories. There are no investor complaints pending.

Citurgia Biochemicals Ltd has announced that its Board of Directors will meet on February 14, 2026, to consider and approve the unaudited standalone financial results for the quarter ended December 31, 2025. The trading window for the company's directors, officers, designated employees, and other connected persons will close on January 1, 2026, and will open 48 hours after the financial results are declared to the stock exchanges.